CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...